Non-invasive characterization of pericyte dysfunction in mouse brain using functional ultrasound localization microscopy
- PMID: 40738972
- DOI: 10.1038/s41551-025-01465-x
Non-invasive characterization of pericyte dysfunction in mouse brain using functional ultrasound localization microscopy
Erratum in
-
Publisher Correction: Non-invasive characterization of pericyte dysfunction in mouse brain using functional ultrasound localization microscopy.Nat Biomed Eng. 2025 Aug 11. doi: 10.1038/s41551-025-01494-6. Online ahead of print. Nat Biomed Eng. 2025. PMID: 40790277 No abstract available.
Abstract
Early microscopic-scale pericyte dysfunction contributes to the initial stages of many neurological diseases and represents a strong candidate target for therapeutic intervention. A non-invasive imaging modality able to image microvascular alterations induced by pericyte dysfunction is needed. In addition, the development of pericyte-focused therapies remains challenging due to the lack of early biomarkers of disease progression. Here we show that cerebral microvascular alterations induced by pericyte dysfunction can be characterized non-invasively in mice using functional ultrasound localization microscopy (fULM). Depletion of endothelial endoglin in adult mice as a model of hereditary haemorrhagic telangiectasia, leads to pericyte detachment in the arteriole-capillary transition (ACT) zone. Imaging reveals that arteriolar capillaries have irregular shapes, increased diameters, reduced blood speed and neurovascular uncoupling mainly localized in the ACT zone. Transforming growth factor-β signalling activator C381 restores pericyte coverage and neurovascular response. Our study underscores the potential of fULM in characterizing early microvascular alterations. As super-resolution ultrasound transitions to the clinic, our data support its future use in monitoring pericyte-focused therapies in humans.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: M.T. and T.D. are co-founders and shareholders of the Iconeus company, which commercializes ultrasound neuroimaging scanners. M.T. is a co-inventor of patent WO2012080614A1 filed on 16 December 2010 and licenced to Iconeus company. All other authors declare no competing interests.
References
Grants and funding
- PTO 446002501/ZonMw (Netherlands Organisation for Health Research and Development)
- ANR-22-CE19-0034-03/Agence Nationale de la Recherche (French National Research Agency)
- 101070917/EC | EU Framework Programme for Research and Innovation H2020 | H2020 European Institute of Innovation and Technology (H2020 The European Institute of Innovation and Technology)
- NNF21CC0073729/Novo Nordisk Fonden (Novo Nordisk Foundation)
LinkOut - more resources
Full Text Sources
Research Materials